This approach encompasses contaminants from diverse chemical families acting through similar modes of action, and makes possible a cumulative risk assessment in indoor environments. The main limitation remains the lack of comparable toxicological data.
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Introduction
Semi-volatile organic compounds (SVOCs) include numerous molecules belonging to different chemical families such as phthalates, polycyclic aromatic hydrocarbons (PAHs), musks, polybromodiphenyl ethers (PBDEs), polychlorobiphenyls (PCBs) or pyrethroid insecticides (Weschler and Nazaroff, 2008) . They can be defined as "organic compounds with vapour pressures between 10 -14 and 10 -4 atm (10 -9 to 10Pa)" and whose boiling point is between (240 to 260°C) and (380 to 400°C) (NF ISO 16000-6, 2006 ) (Weschler and Nazaroff, 2008) . They are used for their technical properties in a large variety of building materials and consumer products (plastics, paints, cleaning agents, biocides, furniture, etc.), and are also emitted by combustion processes. Due to their widespread usage and chemical properties, their presence is ubiquitous in indoor environments, in both settled dust and air (gaseous phase and particulate matter) (Mercier et al., 2011 , Blanchard et al., 2014 . Many SVOCs are suspected of having endocrine disruption mechanisms, leading to potential effects on male reproduction. Among them, phthalates are considered anti-androgenic compounds, responsible for an inhibition of steroidogenesis (Svechnikov et al., 2008) , leading to a decrease in anogenital distance and nipple retention, as well as an increase in the incidence of hypospadias and cryptorchidism in rats exposed during the prenatal period (Gray et al., 2000) . A significant decrease in serum testosterone levels was observed in rodents following oral exposure to BDE-99 , benzo [a] pyrene (B(a)P) (Liang et al., 2012) or cypermethrin (Jin et al., 2011) . In addition, in rats, cypermethrin decreases expression of the androgen receptor after 2 weeks of oral exposure (Liu et al., 2010) .
The effects of bisphenol A (BPA) on testosterone synthesis may be controversial, yet further studies have shown BPA to have negative effects on this hormone. For example, Salian et al.
observed a significant decrease in testosterone concentration in rats pre and postnatally exposed M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT (Salian et al., 2009 ). Della Seta et al. observed the same phenomenon following exposure from postnatal day 23 to postnatal day 30 (Della Seta et al., 2006) .
In humans, authors have demonstrated in vitro endocrine disruption properties for a mixture including phthalates and BPA (Christen et al., 2012) and also for DEHP and MEHP alone (Desdoits-Lethimonier et al., 2012) .
SVOC endocrine properties have also been suggested through epidemiological studies. Hauser et al. observed a dose-dependent negative association between monobutyl phthalate (MBP) and sperm concentration and motility in a population of 463 male partners of subfertile couples (Hauser et al., 2006) . Others groups found similar results between MBP and MEP exposure, and sperm mobility / concentration (Duty et al., 2003) ; metabolites of long-chained phthalates (MEHP and MiNP) and testosterone production (Meeker et al., 2009 ); MBP and MEHP and serum-free testosterone (Pan et al., 2006) ; flame retardant (PBDEs) and serum testosterone concentration (Johnson et al., 2013) , and sperm quality ; BPA and male sexual function (Li et al., 2010) or semen quality (Meeker et al., 2010) . Alteration of protein expression can represent important key events in a modes of action (MOAs), or molecular initiating event in an adverse outcome pathways (AOPs), leading to an adverse outcome (Chepelev et al., 2014) . Sonich-Mullin defined MOA as a "biologically plausible series of key events leading to an effect" (Sonich-Mullin et al., 2001 ). An AOP is conceptually similar to a MOA but includes an initial point of interaction of a chemical with biological systems . It is difficult to know and understand the entire MOA/AOP leading to reprotoxic effects but with a view of the preview information, we can consider the alteration of protein synthesis (e.g. testosterone) as a potential early key event leading to reprotoxic effects.
As underline by Chepelev, protein expression analysis could contributed in health risk assessment (Chepelev et al., 2014) . Thus, Cumulative Risk Assessment (CRA) could be used to address this M A N U S C R I P T
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concern, with a view to assessing whether environmental exposure levels to SVOCs pose a risk, and to help set maximum exposure levels not to be exceeded in indoor environments. A variety of CRA methodologies have already been suggested and recently reviewed (Fournier et al., 2014a) .
Some of them, including toxic equivalency factors (TEF) and relative potency factors (RPF) approaches have been used to identify relative toxic potencies on various chemical mixtures. This is the case of dioxins and PCBs (Ahlborg et al., 1994) ; polychlorinated dibenzo-p-dioxins (PCDD) (OME, 1985) ; pesticides (Jensen et al., 2013) and PAHs (Nisbet and LaGoy, 1992) .
These approaches are based on the dose additivity assumption (Loewe and Muischnek, 1926) as suggested by the US EPA (US EPA, 2002) and consider a common mode of action (US EPA, 2000) . This assumption does not take into account the possibility of toxicological interactions that are not, or are rarely expected with exposure to low doses of contaminants (ATSDR, 2004) .
These approaches were extended to other SVOCs including phthalates, fungicides or pyrethroids (Christiansen et al., 2012; Hannas et al., 2011; Kortenkamp and Faust, 2010; Wolansky et al., 2005) , but none of them is based on real exposure, where a variety of chemical families are encountered.
The aim of this work is to estimate RPFs based on comparable benchmark doses (BMDs) for multiple reprotoxic contaminants present in indoor environments. The choice of the BMD rather than the NOAEL/LOAEL as an indicator of the toxicity was decided to reduce uncertainty due to data heterogeneity (EFSA, 2006) .
Material and Method
Selection and grouping of indoor SVOCs
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The selection of chemicals was made on the basis of different measurement campaigns in French dwellings (Mandin et al., 2014a (Mandin et al., , 2014b Blanchard et al., 2014) , where 66 compounds selected from a previous ranking (Bonvallot et al., 2010) were simultaneously analysed in a range of environmental media (air, gas phase or particle matter, settled dust) using a multi-residue method (Mercier et al., 2012 (Mercier et al., , 2014 . SVOCs were selected where they were detected in more than 10% of the investigated houses (from 30 to 285 according to the campaign).
SVOC grouping was based on our previously described approach (Fournier et al., 2014b) .
Briefly, hazard identification, for each chemical, was performed by means of a literature review on its reprotoxic effects. To be eligible, the toxicological studies (in vivo or in vitro) should describe the target organs or cells, or the mechanisms of action on the male reproductive system or organs. SVOCs were then grouped by common effect, mode and/or mechanism of action.
According to the data, and in order to estimate RPFs, we chose to select the group including the largest number of SVOCs, and for which a biological pathway is known.
Benchmark doses derivation
The BMD is defined as a dose (or concentration) producing a predetermined change in the response rate of an effect (known as the benchmark response or BMR) compared with the background response rate of this effect (US EPA, glossary:
http://www.epa.gov/risk_assessment/glossary.htm). It provides a quantitative indicator of the toxicity of a compound based on the modelling of the entire dose-response relationship. BMDs were derived by means of the following steps: i) selection of suitable dose-response datasets, ii) choice of BMR, iii) fitting models using experimental data, and iv) selection of the best fitting model.
For each compound, we based our BMD calculation on one selected study, describing the most robust dose-response dataset. This kind of approach was also applied recently by Chepelev in M A N U S C R I P T
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order to derive BMDs for the protein expression involved in testicular toxicity (Chepelev et al., 2014) .
Selecting dose-response datasets
For each SVOC, available dose-response datasets were collected and selected on the basis of a compromise between the amount of data available and comparability of the data between compounds. The following criteria were used: i) availability of data for at least 3 dose levels and 1 control group; ii) same species (though not necessarily the same strain); iii) same window of susceptibility (but not necessarily the same exposure duration); iv) same exposure route; v) availability of raw data or means and standard errors of the means (SEM) or standard deviations (SD) for each selected response. Where SDs were not provided in the publication and could not be collected from the authors, a graphical estimation was made as described by the US EPA (US EPA, 2005). If only SEMs were given, these were converted to SDs using the following equation:
, where n is the sample size.
Choice of BMR for a common effect
The response chosen should be linked to a reproductive effect and related to a maximum number of SVOCs in order to consider a CRA. The Benchmark Response (BMR) is associated with the BMD as a change in response relative to background (Crump, 1984) . According to the data, this response could be continuous (e.g., relative change from the control) or dichotomous (e.g., presence or absence of an effect) (US EPA, 2012). In case of RPF derivation, the response should either be linked to a specific mechanism of action or a consequence of a common mode of action (a biological pathway leading to an adverse effect on the reproductive system). Because this M A N U S C R I P T
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response occurs at organism or cellular scale, it is a continuous response. Response rates in each dataset were expressed as a proportion of the background response rate (i.e. background=1).
Where the adverse effect threshold is unknown, the BMRs used in this study will be default values recommended by the US EPA (e.g., a decrease of 1 control SD for continuous datasets and 10% for dichotomous dataset) or a response level that would be qualified as adverse.
Selection of the best fitting model
BMDs were computed using the PROAST software (www.rivm.nl/proast v32.2). The data was continuous summary data (raw data was rarely available) and the Hill family of models was selected for modelling the dose-response relationships, as follow in equations 1 to 4 (2 to 4 parameters):
Where x is toxic compound concentration, a is the background response, b is the concentration of the compound inducing 50% of the effect, d is the slope, and a*c is the response to an infinite dose. The best fitting model from the Hill family was selected according to the procedure described by Slob (Slob, 2002) with the likelihood ratio test. This tests whether increasing the number of parameters in a model results in a statistically significant improvement to fit.
M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT
RPF estimation
RPFs were estimated using the previously-derived BMDs, according to the equation below:
Where RPF i is the RPF of the compound "i"; BMD i is the BMD of the compound "i"; BMD ref is the BMD of the reference compound.
RPFs express the potency of a compound "i" according to the reference compound. This reference compound can be the most toxic compound within a group of compounds, or the most documented for the selected effect.
Results
Fifty-eight SVOCs were selected based on the criteria described in the previous section, and are presented in table 1. Of these, 23 were documented as having male reprotoxic properties regardless of the mode or mechanism of action. A more precise description lead to the identification of 3 groups having different modes of action and potentially acting via different biological pathways. These pathways are summarized in figure 1 (adapted from Fournier et al. 2014a ).
The group including the largest number of SVOCs -and for which the biological pathway is known -is the group whose effect is described as decreasing the concentration of steroidogenesis enzymes, resulting in a lower testosterone level; 18 SVOCs were concerned. Lindane, dieldrin, alpha-endosulfan, chlorpyrifos-ethyl, deltamethrin, triclosan, 4-tertoctylphenol and BDE-99 were excluded because there was no available dose-response relationship for this effect (only one-and two-tested doses, respectively). Four other SVOCs were excluded (permethrin, DBP, DiBP, DiNP) due to lack of comparable data (exposure of rodents during different windows of susceptibility, i.e. pre-or post-natal).
The central estimation (BMD) was used as the basis for calculation of RPFs rather than the BMDL (Benchmark Dose Lower Bound = lower limit of a one-sided confidence interval on the BMD) which integrates uncertainty to experimental data, as suggested by the US EPA in 2010 (US EPA, 2010). Table 2 briefly summarizes the selected study protocols and the decrease in serum testosterone relative to control results. In each case, dose-response data was obtained in adult rats orally exposed through sub-chronic to chronic exposure (15 to 150 days). There are 9 orders of magnitude between the highest dose tested (for DEHP) and the lowest one (for BPA).
Choice of Response and BMR
Serum testosterone concentration was measured in all studies. A decrease in this response was observed according to dose. It is reasonable to consider that this decrease may be linked to adverse effects such as cryptorchidism, hypospadias or male fertility impairment, depending on the window of susceptibility, as suggested by a group of experts of the United Nations Environment Programme (UNEP) and WHO (WHO/UNEP, 2013). Two different BMRs were chosen: a 10% and a 50% decrease in response compared to control serum testosterone. We M A N U S C R I P T
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consider a decrease of 50% of the serum testosterone to be significant (equivalent to the highest documented standard deviation in our selected SVOCs). The use of a BMR equivalent to 1 control standard deviation from the control mean is recommended by the US EPA (US EPA, 2012). The use of 10% as a BMR is intended to compare contaminants' toxicity at lower doses, though authors consider this effect size not meaningful. Eisenberg and colleagues observed a 10% difference in testosterone concentration between fertile and infertile men (Eisenberg et al., 2011) . Furthermore, a 10% decrease in serum testosterone corresponds to the lowest documented standard deviation in our selected SVOCs.
BMD Estimations
The corresponding BMD 10 and BMD 50 are shown in table 3 (associated graphs are shown in supplementary data). Equation 2, with 3 estimated parameters and a null response at infinite doses, was selected for BPA. Equation 3, with 3 estimated parameters, slope equal to 1 and a non-null response at infinite doses, was selected for DEHP. Equation 1, with 2 free parameters, slope equal to 1 and a null response at infinite doses, was selected for the other four SVOCs.
Since the response at infinite doses is equal to 0, BMD 50 is the dose resulting in a 50% decrease relative to the background response. Resulting RPFs for a 10% (RPF 10 ) and 50% (RPF 50 ) decrease are shown in table 4. The control values were included in the BMD calculations.
Discussion and Conclusion
In this study, we derived BMDs for 6 SVOCs pertaining to different chemical families to which people are exposed in indoor environments, leading to RPF for BBP, BPA, B[a]P, DEP, DEHP M A N U S C R I P T
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and cypermethrin. We have adapted the traditional risk assessment approach (NRC, 1983) by adding a grouping step, depending on SVOCs' effects, as suggested in our previous work (Fournier et al, 2014b) . This was done on the basis of their mode of action. In a second step, we calculated BMDs for the 6 SVOCs for which we were able to obtain sufficient information, which in turn allowed RPFs to be derived.
The RPFs calculation is based on the dose additivity assumption because it seems to best describe the reality of mixture toxicity. In fact, the toxic equivalency and dose additivity models have already proved their potency in the mixture effects prediction. For example, Rider et al., in 2008, tested different hypotheses for predicting mixture reproductive effects in male offspring rats exposed during the period of sexual differentiation (Rider et al., 2008) . They compared the observed responses from a mixture of 4 pesticides and 3 phthalates with predicted responses generated using a toxic equivalency approach and dose addition, response addition or integrated addition models. They validated the dose additivity assumption and showed that toxic equivalency and dose addition models provide the best fit to their observed responses even for chemicals from different families which do not necessarily act via the same cellular mechanism of action. There were several reasons for basing our RPF calculation on a 10% and 50% decrease in testosterone synthesis (BMD 10 and BMD 50 ), defined respectively as RPF 10 and RPF 50 . First of all, as mentioned above, we do not know which level of inhibition of testosterone is harmful to human health. In this case, the US EPA recommends the use of an endpoint that is equivalent to a decrease of 1 control SD (US EPA, 2012). In our case, we have chosen to apply respectively the smallest and the largest of the documented control SDs (near 50% for BBP and 10% for BPA) for the choice of BMR.
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We chose cypermethin as the index compound because its range of tested doses is intermediate among those tested for the other SVOCs. The difference in ranges of tested doses and toxicity between contaminants yields a large range of RPF values (a factor of 10 9 between BPA and BBP for RPF 10 , a factor of 10 6 between B[a]P and BBP). The choice of the reference compound, however, modifies neither the toxicity of each contaminant nor the order of their potency for the effect of interest.
According to the RPF 10 , BPA shows the most toxic among the considered SVOCs (7, 033, 679 times more potent than cypermethrin for this effect) and BBP the least toxic (10.5 times less potent than cypermethrin). According to the RPF 50 , B(a)P seems to be the most toxic (1,630 times more potent than cypermethrin for this effect) and BBP the least one (10.5 times less potent than cypermethrin).
For a 50% reduction in testosterone levels, we can observe that B(a)P is more toxic than BPA, while this latter is most potent at 10% of the effect. According to our data, BPA is the most potent of of the study SVOCs at low doses. This is due to the difference between BPA and the other SVOCs in terms of the slope of the curves (inclusion of the "d" parameter, see equation 2).
Our data does not allow to derive a BMD 50 (and RPF 50 ) for DEHP because, according to the Hill equation used by PROAST, when the DEHP concentration is infinite, the response (decrease in serum testosterone concentration) only approaches 0.43 (=BMD 43 ). The derivation of a BMD 50
for the DEHP could be performed with other data which investigated the same response, but specifically in pubertal rats (Noriega et al., 2009 ). According to this data, the BMD 10 would be 102.45 mg/kg bw/day and the BMD 50 922.07 mg/kg bw/day.
We see here that the BMD 10 based on adult data from Tonk et al. is 20 times lower than the BMD 10 based on pubertal rat from Noriega et al. This comparison shows that the toxic potency of DEHP compared to other compounds could be modified regarding to the window of exposure, leading difficult the extrapolation of the "pubertal" BMD 50 to an "adult" BMD 50 .
In our case, three SVOCs (B[a]P, DEP and BBP) had parallel dose-response curves compared to the reference compound's curve (cypermethrin) with a slope equal to 1 and a response at infinite concentrations equal to 0. On the other hand, for DEHP, at infinite concentrations, the response only approaches 0.43 rather than 0 and for BPA, the slope was different from 1. In these cases, the dose-response curves were not parallel compared to the reference. Thus, from a statistical point of view, the RPFs for B[a]P, DEP and BBP are more reliable than those for DEHP and BPA.
The main limitation of this work in a perspective of CRA for chemicals humans are exposed to, is the lack of available and comparable data in the scientific literature. Among the 58 SVOCs that were considered, others than the one we could include might be reprotoxic, but no study has been published to date. Only 23 have been documented as having reprotoxic properties. Of these, 18 are able to decrease testosterone synthesis. At the final step, the literature provided sufficient comparable information for BMD calculation only for 6.
This limitation of the available information was recently underlined by Wignall et al. in their standardization of BMD calculations (Wignall et al., 2014) . Another impediment is the lack of comparability of the data in terms of the range of tested doses, windows of exposure, animal strain, time of exposure, etc. The most striking example is the tested doses range, from 0.000005 mg/kg bw/day for BPA, to 1000 mg/kg bw/day for DEHP, suggesting that BPA is the most M A N U S C R I P T
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potent toxic SVOC of our group for the study effect (abatement of serum testosterone concentration); however, its action remains a subject of controversy in the literature. Our requirements in term of data comparability (same species, same window of exposure, etc.) and obviously the lack of data availability limit the datasets for our RPF computations. The more precise and comparable we require our data to be, the less such data is available.
There is no data to compare with in the literature regarding RPFs derived from a variety of chemical families. Among phthalates, RPFs were derived for DEHP and BBP acting on testosterone synthesis (Benson, 2009; Hannas et al., 2011) . Based on (Mandin et al., 2014a) ; (Mandin et al., 2014b) ; (Blanchard et al., 2014) M A N U S C R I P T 
